Skip to main content

Genomenon Mastermind

Genomenon has launched Mastermind, an analytic and data visualization tool that accelerates gene and variant curation. The software mines millions of medical publications and delivers a comprehensive knowledge base of disease-gene-variant relationships curated from primary medical literature, organized into clinical categories, and prioritized by the strength of evidence, the company said. Mastermind has reviewed literature and found associated variants for all the genes from Thermo Fisher Scientific's Ion AmpliSeq comprehensive cancer panel; Illumina's TruSight Tumor 170 solid tumor cancer panel; Thermo Fisher's and Fulgent's hereditary cancer panels; and Thermo Fisher's, Illumina's, and Fulgent's cardiomyopathy panels.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.